Good correlation between RT-PCR analysis of BCR-ABL transcript and relapse in 18 cases of Philadelphia (PH1) acute lymphoblastic leukemia (ALL)

被引：0
|
作者：
Preudhomme, C
Henic, N
Cazin, B
Lai, JL
Lemoine, F
Jouet, JP
Szapiro, N
Nelken, B
Cosson, A
Fenaux, P
机构：
[1] CHU BESANCON, F-25030 BESANCON, FRANCE
[2] CHU LILLE, F-59037 LILLE, FRANCE
[3] CHU ANGERS, ANGERS, FRANCE
[4] CHU ST ETIENNE, ST ETIENNE, FRANCE
来源：
BLOOD | 1996年 / 88卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1899 / 1899
页数：1
相关论文
共 50 条
  • [21] Validation of a single tube quantitative real-time RT-PCR (QRT-PCR) assay for the detection and quantification of the BCR-ABL minor breakpoint in acute lymphoblastic leukemia (ALL).
    Siddiqui, R
    Dumur, CI
    Ladd, AC
    Wilkinson, DS
    Carleton, GT
    Ferreira-Gonzalez, A
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2005, 7 (05): : 662 - 662
  • [22] One-tube multiplex RT-PCR of BCR-ABL transcripts in analysis of patients with chronic myeloid leukaemia and acute lymphoblastic leukaemia
    Nogva, HK
    Evensen, SA
    Madshus, IH
    SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 1998, 58 (08): : 647 - 654
  • [23] Quantitative and competitive RT-PCR and ''in cell RT-PCR'' for the detection of BCR-ABL transcript in chronic myeloid leukemia patients: Comparison of advantages and pitfalls of two promising methods.
    Martinelli, G
    Testoni, N
    Farabegoli, P
    Zaccaria, A
    Amabile, M
    Raspadori, D
    Pelliconi, S
    Terragna, C
    Vittone, A
    Tura, S
    BLOOD, 1996, 88 (10) : 2280 - 2280
  • [24] Comprehensive analysis of BCR-ABL transcript types in Korean CML patients using a newly developed multiplex RT-PCR
    Goh, Hyun-Gyung
    Hwang, Ji-Yeon
    Kim, Soo-Hyun
    Lee, Young-Hoon
    Kim, Yoo-Li
    Kim, Dong-Wook
    TRANSLATIONAL RESEARCH, 2006, 148 (05) : 249 - 256
  • [25] Multiplex RT-PCR does not distinguish between a Bcr-Abl transcript lacking Abl exon a2 (ALL) and b2a2 transcripts (CML)
    Merle, PA
    Theijsmeijer, P
    Janssen, JJWM
    Ossenkoppele, GJ
    Van Oostveen, JW
    BRITISH JOURNAL OF HAEMATOLOGY, 1998, 102 (01) : 110 - 110
  • [26] Ultrasensitive NGS MRD assessment in Ph plus ALL: Prognostic impact and correlation with RT-PCR for BCR::ABL1
    Short, Nicholas J.
    Jabbour, Elias
    Macaron, Walid
    Ravandi, Farhad
    Jain, Nitin
    Kanagal-Shamanna, Rashmi
    Patel, Keyur P.
    Loghavi, Sanam
    Haddad, Fadi G.
    Yilmaz, Musa
    Issa, Ghayas C.
    Kebriaei, Partow
    Kornblau, Steven M.
    Pelletier, Sarah
    Flores, Wilmer
    Matthews, Jairo
    Garris, Rebecca
    Kantarjian, Hagop
    AMERICAN JOURNAL OF HEMATOLOGY, 2023, 98 (08) : 1196 - 1203
  • [27] High frequency of BCR-ABL oncogene in pediatric acute lymphoblastic leukemia (ALL) patients as revealed by RT-PCR and interphase FISH: Association with disease biology and treatment outcome.
    Iqbal, Zafar
    Awan, Tashfin
    Iqbal, Mudassar
    Sabir, Noreen
    Asad, Sultan
    Siddique, Mohammad Hasan
    Sahar, Sumrin
    Tahir, Ammara H.
    Aleem, Aamer
    Akhtar, Tanveer
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [28] DETECTION OF RARE COPIES OF BCR-ABL1 TRANSCRIPT IN PATIENTS WITH PHILADELPHIA POSITIVE (PH+) ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) WITH A HIGH SENSITIVE NANOFLUIDIC ARRAY
    Lonetti, A.
    Iacobucci, I.
    Ferrari, A.
    Papayannidis, C.
    Paolini, S.
    Cilloni, D.
    Abbenante, M. C.
    Guadagnuolo, V.
    Pane, F.
    Baccarani, M.
    Martinelli, G.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 90 - 90
  • [29] Monitoring of minimal residual disease in patients with BCR-ABL positive acute lymphoblastic leukemia using a real-time RT-PCR assay.
    Chi, HS
    Choi, SJ
    Shim, EH
    Seo, EJ
    Park, CJ
    BLOOD, 2003, 102 (11) : 228B - 228B
  • [30] Serial monitoring of BCR-ABL in newly diagnosed Philadelphia chromosome-positive (Ph plus ) acute lymphoblastic leukemia (ALL) treated with imatinib.
    Lim, Sung-Nam
    Joo, Young-Don
    Kim, Ii-Hwan
    Lee, Won-Sik
    Lee, Sang Min
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
12345